Vancouver, British Columbia, January 9, 2026 — Burcon NutraScience Corporation (“Burcon” or the “Company”) (TSX: BU) (OTCQB: BRCNF), a global technology leader in plant-based protein innovation, is pleased to announce that, in response to strong demand, it has increased the size of its previously announced non-brokered private placement (the “Private Placement”) of convertible debentures (the…
Vancouver, British Columbia, January 2, 2026 — Burcon NutraScience Corporation (“Burcon” or the “Company”) (TSX: BU) (OTCQB: BRCNF), a global technology leader in plant-based protein innovation, is pleased to announce the closing of the first tranche of a non-brokered private placement of convertible debentures (the “Convertible Debentures”) for an aggregate principal amount of up to…
Accelerating Demand Driving Strong Revenue Growth Vancouver, British Columbia, December 15, 2025 — Burcon NutraScience Corporation (“Burcon” or the “Company”) (TSX: BU) (OTCQB: BRCNF), a global technology leader in plant-based protein innovation, is pleased to issue a letter to shareholders from its Chief Executive Officer, Kip Underwood. Dear Fellow Shareholders, 2025 was a transformational year…
Vancouver, British Columbia, December 1, 2025 — Burcon NutraScience Corporation (“Burcon” or the “Company”) (TSX: BU) (OTCQB: BRCNF), a global technology leader in plant-based protein innovation, is pleased to announce that the Company insiders (“Insiders”) have increased their commitment to participating in the previously announced non-brokered private placement (the “Offering”) (see news release of the…
Vancouver, British Columbia, November 12, 2025 — Burcon NutraScience Corporation (“Burcon” or the “Company”) (TSX: BU) (OTCQB: BRCNF), a global technology leader in plant-based protein innovation, reported results for the fiscal second quarter ended September 30, 2025. “Protein sales are gaining momentum as customers complete evaluations and transition to purchase orders,” said Kip Underwood, Burcon’s…
Vancouver, British Columbia, November 12, 2025 — Burcon NutraScience Corporation (“Burcon” or the “Company”) (TSX: BU) (OTCQB: BRCNF), a global technology leader in plant-based protein innovation, is pleased to announce a non-brokered private placement of convertible debentures (the “Convertible Debentures”) for an aggregate principal amount of up to $4 million (the “Offering”). Insiders of the…
Vancouver, British Columbia, November 6, 2025 — Burcon NutraScience Corporation (“Burcon” or the “Company”) (TSX: BU) (OTCQB: BRCNF), a global technology leader in plant-based protein innovation, will hold an investor conference call and webcast on Wednesday, November 12, 2025 at 5:00 p.m. Eastern time to discuss its financial results for the fiscal 2026 second quarter…